Public health case for microbiome-sparing antibiotics and new opportunities for drug development

L. Clifford McDonald, Vincent B. Young, Mark H. Wilcox, Alison Laufer Halpin, Ricardo L. Chaves

Open source

DOI
10.1128/msphere.00417-24
Published
2024-08-28
Container
mSphere
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/msphere.00417-24,
  title = {Public health case for microbiome-sparing antibiotics and new opportunities for drug development},
  author = {L. Clifford McDonald and Vincent B. Young and Mark H. Wilcox and Alison Laufer Halpin and Ricardo L. Chaves},
  year = {2024},
  journal = {mSphere},
  doi = {10.1128/msphere.00417-24},
  url = {https://doi.org/10.1128/msphere.00417-24}
}

RIS

TY  - JOUR
TI  - Public health case for microbiome-sparing antibiotics and new opportunities for drug development
AU  - L. Clifford McDonald
AU  - Vincent B. Young
AU  - Mark H. Wilcox
AU  - Alison Laufer Halpin
AU  - Ricardo L. Chaves
PY  - 2024
JO  - mSphere
DO  - 10.1128/msphere.00417-24
UR  - https://doi.org/10.1128/msphere.00417-24
ER  - 

APA

McDonald, L. C., Young, V. B., Wilcox, M. H., Halpin, A. L., & Chaves, R. L. (2024). Public health case for microbiome-sparing antibiotics and new opportunities for drug development. mSphere. https://doi.org/10.1128/msphere.00417-24

Source records